The Food and Drug Administration said Monday it sent warning letters to more than a dozen companies the agency said are “illegally selling” products that claim to prevent or cure Alzheimer’s disease.
Many of these products, which are often sold on websites and social media platforms, “have not been reviewed by the FDA and are not proven safe and effective to treat the diseases and health conditions they claim to treat,” the FDA said in a press release.
“These products may be ineffective, unsafe and could prevent a person from seeking an appropriate diagnosis and treatment,” the agency added. The FDA is responsible for taking action against any misbranded dietary supplement product after it reaches the market.
The companies have 15 days to respond to the FDA. It’s not clear what happens after that. See their press release here.
RELATED: FDA Commissioner Scott Gottlieb, appointed in early 2017, is a right wing medical doctor and former lobbyist for Big Pharma. Prior to his appointment, he was a frequent critic of Obamacare for Fox News.